Volume 88, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Tennessee has a high incidence of Rocky Mountain spotted fever (RMSF), the most severe tick-borne rickettsial illness in the United States. Some regions in Tennessee have reported increased illness severity and death. Healthcare providers in all regions of Tennessee were surveyed to assess knowledge, attitudes, and perceptions regarding RMSF. Providers were sent a questionnaire regarding knowledge of treatment, diagnosis, and public health reporting awareness. Responses were compared by region of practice within the state, specialty, and degree. A high proportion of respondents were unaware that doxycycline is the treatment of choice in children ≤ 8 years of age. Physicians practicing in emergency medicine, internal medicine, and family medicine; and nurse practitioners, physician assistants, and providers practicing for < 20 years demonstrated less knowledge regarding RMSF. The gaps in knowledge identified between specialties, designations, and years of experience can help target education regarding RMSF.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Centers for Disease Control and Prevention, 2010. Summary of notifiable diseases–United States, 2008. MMWR Morb Mortal Wkly Rep 57: 29. [Google Scholar]
  2. Adjemian JZ, Krebs J, Mandel E, McQuiston J, , 2009. Spatial clustering by disease severity among reported Rocky Mountain spotted fever cases in the United States, 2001–2005. Am J Trop Med Hyg 80: 7277. [Google Scholar]
  3. Sexton DJ, Walker DH, Guerrant RL, Walker DH, Weller PF, , 2006. Spotted fever group rickettsioses. , eds. Tropical Infectious Diseases: Principles, Pathogens, and Practice. Second edition. Philadelphia, PA: Elsevier Churchill Livingstone, 539547.[Crossref] [Google Scholar]
  4. Helmick CG, Bernard KW, D'Angelo LJ, , 1984. Rocky Mountain spotted fever: clinical, laboratory, and epidemiological features of 262 cases. J Infect Dis 150: 480488.[Crossref] [Google Scholar]
  5. Dalton MJ, Clarke MJ, Holman RC, Krebs JW, Fishbein DB, Olson JG, Childs JE, , 1995. National surveillance for Rocky Mountain spotted fever, 1981–1992: epidemiologic summary and evaluation of risk factors for fatal outcome. Am J Trop Med Hyg 52: 405413. [Google Scholar]
  6. Buckingham SC, Marshall GS, Schutze GE, Woods CR, Jackson MA, Patterson LE, , 2007. Clinical and laboratory features, hospital course, and outcome of Rocky Mountain spotted fever in children. J Pediatr 150: 180184.[Crossref] [Google Scholar]
  7. Kirkland KB, Wilkinson WE, Sexton DJ, , 1995. Therapeutic delay and mortality in cases of Rocky Mountain spotted fever. Clin Infect Dis 20: 11181121.[Crossref] [Google Scholar]
  8. Purvis JJ, Edwards MS, , 2000. Doxycycline use for rickettsial disease in pediatric patients. Pediatr Infect Dis J 19: 871874.[Crossref] [Google Scholar]
  9. Holman RC, Paddock CD, Curns AT, Krebs JW, McQuiston JH, Childs JE, , 2001. Analysis of risk factors for fatal Rocky Mountain spotted fever: evidence for superiority of tetracyclines for therapy. J Infect Dis 184: 14371444.[Crossref] [Google Scholar]
  10. American Academy of Pediatrics Pickering LK, Baker CJ, Kimberlin DW, Long SS, , 2012. Ehrlichia and Anaplasma infections, Rocky Mountain spotted fever. , eds. Red Book: 2012 Report of the Committee on Infectious Diseases. 29th edition. Elk Grove Village, IL: American Academy of Pediatrics: 312315, 623625. [Google Scholar]
  11. O'Reilly M, Paddock C, Elchos B, Goddard J, Childs J, Currie M, , 2003. Physician knowledge of the diagnosis and management of Rocky Mountain spotted fever: Mississippi, 2002. Ann N Y Acad Sci 990: 295301.[Crossref] [Google Scholar]
  12. Lochary ME, Lockhart PB, Williams WT, Jr, 1998. Doxycycline and staining of permanent teeth. Pediatr Infect Dis J 17: 429431.[Crossref] [Google Scholar]
  13. Openshaw JJ, Swerdlow DL, Krebs JW, Holman RC, Mandel E, Harvey A, Haberling D, Massung RF, McQuiston JH, , 2010. Rocky Mountain spotted fever in the United States, 2000–2007: interpreting contemporary increases in incidence. Am J Trop Med Hyg 83: 174182.[Crossref] [Google Scholar]
  14. Kirkland KB, Wilkinson WE, Sexton DJ, , 1995. Therapeutic delay and mortality in cases of Rocky Mountain spotted fever. Clin Infect Dis 20: 11181121.[Crossref] [Google Scholar]
  15. Centers for Disease Control and Prevention, 2000. Consequences of delayed diagnosis of Rocky Mountain spotted fever in children: West Virginia, Michigan, Tennessee, and Oklahoma, May–July 2000. MMWR Morb Mortal Wkly Rep 49: 885888. [Google Scholar]

Data & Media loading...

  • Received : 23 Feb 2012
  • Accepted : 04 Sep 2012
  • Published online : 09 Jan 2013

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error